SCHEMBL113952

SCHEMBL113952

NC(=O)OCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(CO)s1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 20/20 0.53
ROCK1 Q13464 2/20 0.53
MYLK4 Q86YV6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9883142 0.87 ROCK2 (0.66) ROCK2ROCK1MYLK4
SCHEMBL23398166 0.87 ROCK2 (0.47) ROCK2ROCK1MYLK4
Hydrochloric Acid SCHEMBL112565 0.86 ROCK2 (0.65) ROCK2ROCK1MYLK4
SCHEMBL113963 0.83 ROCK2 (0.53) ROCK2ROCK1MYLK4
SCHEMBL28549445 0.82 ROCK2 (0.76) ROCK2ROCK1MYLK4
SCHEMBL28549443 0.82 ROCK2 (0.76) ROCK2ROCK1MYLK4
SCHEMBL2778216 0.79 ROCK2 (0.47) ROCK2ROCK1MYLK4
SCHEMBL9883169 0.78 ROCK2 (0.50) ROCK2ROCK1MYLK4
SCHEMBL114567 0.75 ROCK2 (0.62) ROCK2ROCK1MYLK4
SCHEMBL111950 0.75 ROCK2 (0.56) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed